Return to content in this issue

Omalizumab in An 8-Year-Old Boy With Diabetes Mellitus and Refractory Chronic Spontaneous Urticaria

Jesenak M¹, Ciljakova M¹, Janickova M², Banovcin P<sup>1

1</sup>Department of Pediatrics, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Teaching Hospital, Martin, Slovakia
²Department of Stomatology and Maxillofacial Surgery, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Teaching Hospital, Martin, Slovakia

J Investig Allergol Clin Immunol 2019; Vol 29(2) : 144-146
doi: 10.18176/jiaci.0351